Viimeisin päivitys :
19/11/2024
syöpälääke   Azacitidine  
Injektioneste
Stabilius liuoksessa Stabilius seoksissa Tekijät, jotka vaikuttavat stabiliuteen Yhteensopivuus Antotapa Viitteet pdf
   Kemiallinen rakenne  

Kauppanimi   Kauppanimi     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Amilix Argentiina
Arquimes Argentiina
Azacimyl Chile
Azacitidina Argentiina, Chile, Marokko
Azacitidine Yhdysvallat
Azacor Marokko
Azadin Turkki
Azamex Argentiina
Azanova Argentiina
Azateva Argentiina
Azida Turkki
Azitech Argentiina
Iclacitidina Marokko
Iterbil Argentiina
Maturus Argentiina
Mietozitidina Argentiina, Marokko
Nimodac Argentiina
Remitiva Argentiina, Chile
Tazadir Argentiina
Vidaza Argentiina, Belgia, Chile, Espanja, Islanti, Iso-Britannia, Kanada, Kolumbia, Malesia, Marokko, Meksiko, New Zealand, Norja, Ranska, Romania, Saksa, Sveitsi, Turkki, Yhdysvallat
Wunduza Chile
Zacidonel Meksiko
Zylatadina Argentiina
Viitteet   Injektioneste   Viitteet : Azacitidine  
tyyppi julkaisu
414 Lehti Den Hartigh J, Brandenburg HCR, Vermeij P.
Stability of azacitidine in lactated Ringer’s injection frozen in polypropylene syringes.
Am J Hosp Pharm 1989 ; 46: 2500-2505.
1039 Lehti Cheung YW, Vishnuvajjala BR, Morris NL, Flora KP.
Stability of azacitidine in infusion fluids.
Am J Hosp Pharm 1984 ; 41: 1156-1159.
3204 Lehti Duriez A, Vigneron J.H, Zenier H.A, May I, Demoré B.M.
Stability of Azacitidine Suspensions.
Ann Pharmacotherapy 2011 ;45, 4:546.
3236 Laboratorio Azacitidine (Vidaza®) - Résumé des caractéristiques du produit
Celgene 2011
3246 ilmoitus Vieillard V, Appudurai O, Voytenko S, Astier A, Paul M.
Stabilité physico-chimique de la suspension d'azacitidine (25 mg/mL) conservée à 4°C.
SFPO Congress Mandelieu, France 2011
3351 Lehti Walker S.E, Charbonneau L.F, Law S, Earle C.
Stability of Azacitidine in Sterile Water for Injection.
Can J Hosp Pharm 2012 ; 65, 5: 352-359
3534 Lehti Legeron R, Xuereb F, Djabarouti S, Saux M.C, Breilh D.
Chemical stability of azacitidine suspensions for injection after cold-chain reconstitution of powder and storage
Am J Health-Syst Pharm 2013 ; 70:2137-2142
3816 ilmoitus Balouzet C, Chanat C, Jobard M, Brandely-Piat ML, Chast F.
Stabilité des poches d'azacitidine pour injection intraveineuse (1- 4 et 2,4 mg/mL) conservées à 4°C.
SFPO Congress, Nantes, France 2015
3818 Lehti Balouzet C, Chanat C, Jobard M, Brandely-Piat M-L, Chast F.
Stability of 25 mg/mL 5-azacitidine suspension kept in fridge after freezing.
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2, 1:11-16.
4227 ilmoitus Tyono I, Law S, Charbonneau L.F, Walker S.E.
Stability of Azacitidine Solutions In Sterile Water for Injection.
Prof Practice Conference - Canadian Society of PH 2019
4628 Lehti Iudicello A, Genovese F, Strusi V, Dominici M, Ruozi B.
Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations.
Pharmaceuticals 2021 ; 14, 943.
4697 Lehti Trambloy Q, Vigneron J, Clarot I, Blaise F, D’Huart E, Demoré B.
Physicochemical stability of azacitidine suspensions at 25 mg/mL in polypropylene syringes stored under different conditions of storage.
Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20220003

  Mentions Légales